CONFERENCE PROCEEDING
Attributable mortality to secondhand smoke exposire in Spain.
 
More details
Hide details
1
Área de Medicina Preventiva y Salud Pública, Universidade de Santiago de Compostela, Santiago de Compostela, Spain
 
2
Control del Cáncer, Institut Català d’Oncologia (ICO), L’Hospitalet de Llobregat Barcelona, Spain
 
3
Hospital Universitario La Paz, Madrid, España. Unidad de Control del Tabaco, Programa de Prevención, Spain
 
 
Publication date: 2023-04-25
 
 
Corresponding author
Mónica Pérez-Ríos   

Area of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Galicia, Spain
 
 
Tob. Prev. Cessation 2023;9(Supplement):A112
 
KEYWORDS
ABSTRACT
Introduction:
Exposure to secondhand smoke (SHS) is associated with an increase in mortality and morbidity. The aim of this work is to estimate the impact of the exposure to SHS on mortality in Spain in the population aged 35 and over in the year 2020.

Material and Methods:
Attributable mortality (AM) to SHS was estimated using a prevalence-dependent method. Prevalence of exposure was derived from a national representative crosssectional study and relative risks from metanalyses. AM estimations were accompanied by 95% confidence intervals (95%CI), which were calculated using a naive bootstrap procedure. AM, globally and by tobacco consumption, was estimated by sex, age group and cause of death. A sensitivity analysis was performed.

Results:
In Spain, in 2020, 747 (95% CI 676-825) deaths in the population aged 35 and over were attributed to exposure to SHS, 279 (95%CI 256-306) due to lung cancer and 468 (95% CI 417-523) due to ischemic heart disease. 75.1% of the AM occurred in men, 561 deaths (95% CI 494-634). 60.9% of deaths attributed to SHS exposure occurred in non-smokers. Including Chronic Obstructive Pulmonary Disease and stroke in the estimation rose the mortality burden to 2,242 deaths.

Conclusions:
Exposure to SHS is an important cause of death in Spain, associated with 1.5% of all deaths from lung cancer and ischemic heart disease in the population aged 35 and over. Most of the AM to SHS occurs in non-smokers. These data reinforce the need for health authorities to commit to reducing the exposure to SHS in any type of context and location.

CONFLICTS OF INTEREST
The authors have no conflicts of interest to declare.
eISSN:2459-3087
Journals System - logo
Scroll to top